| |
|
|
|
The presentations below are 90 second videos of participating investigators describing trial rationales, inclusion and exclusion criteria, required tests, and trial results (if available). To identify presentations on trials that may be appropriate for a specific patient, filter the results by selecting trial phase, tumor type, and trial status.
|
|
| Use the checkboxes to limit the search results to your selected phase(s),tumor type(s) and recruitement staus. |
|
|
|
Fetching results. Please wait....
|
|
Phase II Study of Bevacizumab and Erlotinib in Elderly Patients with Advanced Non-Small Cell Lung Cancer
|
View Presentation
|
|
|
Presented by Dr. Corey Langer, MD
|
|
|
|
A Randomized Phase 3 Trial for Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer
|
View Presentation
|
|
|
Presented by: Lou Fehrenbacher, MD
|
|
|
|
Randomized Phase III Study of Conventional Whole vs Partial Breast Irradiation Stage 0, 1, 2
|
View Presentation
|
|
|
Presented By: Thomas Julian, M.D.
|
|
|
|
Phase III Study-Evaluating the Role of Perioperative Chemo in Patients with Potentially Resectable Hepatic Colorectal Metastases
|
View Presentation
|
|
|
Presented By: Michael A. Choti, MD, MBA
|
|
|
|
Phase III Comparing Trastuzumab with Concurrent Radiation vs Radiation Alone for HER2+ Ductal Carcinoma In Situ Resected By Lumpectomy
|
View Presentation
|
|
|
Presented By: Melody Cobleigh, MD
|
|
|
|
A Randomized, Phase III Trial of Neoadjuvant Therapy for Patients With Palpable and Operable HER2-Positive Breast Cancer Comparing the Combination of
|
View Presentation
|
|
|
Presented by : Andre Robidoux, MD
|
|
|
|
|
|
|
|
|
| |
| |
|
|